Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2026-07-01 @ 3:20 AM
Study NCT ID:
NCT04042558
Status:
COMPLETED
Last Update Posted:
2025-05-31
First Post:
2019-07-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies
Sponsor:
Centre Francois Baclesse
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GFPC 06-2018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |